..

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

Parkinson’s disease: February 19th BIOS E108 Parkin and PINK1
MITOCHONDRIAL DISEASES
MPP OUTSIDE REQUEST FORM Review Date 8/3/11 Requestor(s):Brad Gibson/Liza Pon Institution:Buck Institute, Novato, CA/Columbia University Request Title:mouse.
The Effects of Increased Net Reactive Oxygen Species on Mitophagy DONALD TA.
Parkinson’s Disease Paul Tuite, MD University of Minnesota Director of Movement Disorders.
Chapter 18 Human Heredity by Michael Cummings ©2006 Brooks/Cole-Thomson Learning Chapter 18 Genetics of Behavior.
Aging of the Nervous System: Functional Changes P.S. Timiras.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
Psychlotron.org.uk Schizophrenia: brain chemicals How might neurotransmitters be implicated in mental illness?
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
(12 marks) Outline the biological approach - 6 marks Evaluate the biological approach - 6 marks.
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
Nature vs. Nurture.  Once nurture seemed clearly distinct from nature. Now it appears that our diets and lifestyles can change the expression of our.
AMPAKINE Compounds for the Treatment of Rett Syndrome
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Cristopher Ramirez Psychology Period 6. A common form of dementia, usually beginning in late middle age, characterize by memory lapses, confusion, emotional.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
1 Alzheimer’s Disease & Acetylcholine Presentation by: Huy Nguyen Chemistry 12B Instructor: Dr. Adamczeski Fall-2006.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
Lecture 24 Learning and Memory II. Memories Long term memory stored in cortex Information is processed for memory storage in other brain regions (i.e.
Aging and Reactive oxygen Species. Aging: What is it?  Aging, has been termed generally as a progressive decline in the ability of a physiological process.
Mitochondria in the etiology and pathogenesis of Parkinson's disease
Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009.
Alzheimer’s Disease Gavin Mast, Musa Abdus-Samad, Arash Rezaeian, Sarah Rocha PHM142 Fall 2015 Instructor: Dr. Jeffrey Henderson.
Cell Aging. Aging is generally characterized by the declining ability to respond to stress, increasing homeostatic imbalance and increased risk of aging-associated.
Under the supervision of miklós jászberényi
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Alzheimer’s Disease and the influence of Presenilin 1 By Tony Cortez.
Pathogenesis and pathology of parkinsonism
HUNTINGTON’S DISEASE Neil Madadi. WHAT IS HUNTINGTON’S DISEASE?  It is an autosomal dominant inherited disease. Meaning that only one copy of the altered.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part B – AD and brain systems NUCLEAR MEDICINE GRAND ROUNDS.
 Only caused by: › Inherited genetic defect › Mutation  Defect or mutation is a CAG repeat in the HD gene of chromosome 4  CAG repeat  abnormal Huntingtin.
Alzheimer’s Disease and the influence of Presenilin 1
Reflections on animal models of neurological disorders Marie-Francoise Chesselet UCLA
How experience changes the brain Elizabeth Gould PhD Department of Psychology, Princeton Neuroscience Institute Princeton University.
Chapter 14 Neurocognitive Disorders
Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.
Modelling Madness Susan Totterdell.
(Draw and label a picture of a neurone here)
Title: Alzheimer’s disease and the social
Schizophrenia.
III. Parkinson Disease.
Justin Hayase MSTAR Presentation Guo Lab July 23,2009
Alpha-synuclein in Parkinson's disease
Ch. 7: Neurons: Matter of the Mind Ch. 8: The Nervous System
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
Abstract Mitophagy is essential for cellular homeostasis, but how mitophagy is regulated is largely unknown. Here we found that the kinase Jnk2.
Nat. Rev. Neurol. doi: /nrneurol
Alicia M. Pickrell, Richard J. Youle  Neuron 
Schizophrenia: brain chemicals
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Justin Hayase MSTAR Presentation Guo Lab July 23,2009
Drugs for Degenerative Diseases of the Nervous System
Alzheimer’s Disease and the influence of Presenilin 1
Douglas R. Green, Beth Levine  Cell 
Autophagy in the Pathogenesis of Disease
Neurotransmitters.
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Genetic Animal Models of Parkinson's Disease
Scientific Background
Alzheimer Mechanisms and Therapeutic Strategies
Targets of thiazolidinedione (TZD) drugs in Alzheimer’s disease.
Huntington’s Disease Brett McCraw.
PD-associated gene products and their prospective sites of cellular function PD is hypothesized to be a consequence of the dysfunction of intersecting.
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

.

Schizophrenia; crash course psychology http://www.youtube.com/watch?v=uxktavpRdzU What is schizophrenia? http://www.youtube.com/watch?v=ynin-1yAERY

The biology behind schizophrenia http://www.youtube.com/watch?v=V1kSIfxBVfU Neuroleptics and antipsychotic drugs http://www.youtube.com/watch?v=aGfNBDXYs1Y

Impact (symptoms) of schizophrenia http://www.youtube.com/watch?v=suVEMf9anzE The future of schizophrenia treatment http://www.youtube.com/watch?v=bs-ah3K6js8

6 MUST KNOW SIGNS of DEPRESSION! http://www.youtube.com/watch?v=51vdnwrfsNA

The science of depression http://www.youtube.com/watch?v=GOK1tKFFIQI

Depression is a disease of civilization: Stephen Ilardi at TEDxEmory http://www.youtube.com/watch?v=drv3BP0Fdi8

Depressive and Bipolar Disorders: Crash Course Psychology #30 http://www.youtube.com/watch?v=ZwMlHkWKDwM 5 misunderstandings about Bipolar Disorder - Mental Health Help with Kati Morton http://www.youtube.com/watch?v=oUI5xS_IH24

Daniel My Brother (Huntington's Disease) http://www.youtube.com/watch?v=JzAPh2v-SCQ

The Huntingtin gene provides the genetic information for a protein that is also called "huntingtin". Expansion of a CAG triplet repeat stretch within the Huntingtin gene results in a different (mutant) form of the protein, which gradually damages cells in the brain, through mechanisms that are not fully understood. What is Huntington's Disease? http://www.youtube.com/watch?v=4HgFUvVyHYQ

Tourette’s syndrome http://www.youtube.com/watch?v=jYRa-fpNonY

Parkinson’s disease http://www.youtube.com/watch?v=wWQoLEKq4Wc

Parkinson genes

Nature Editor's summaryinالعر Loss-of-function mutations affecting two enzymes involved in the clearance of damaged mitochondria (mitophagy) — the ubiquitin ligase parkin and the protein kinase PINK1 — are associated with familial Parkinson's disease. Here it is shown that USP30, a deubiquitinase localized to mitochondria, antagonizes mitophagy by removing the ubiquitin tags put in place by parkin. Reducing USP30 activity enhances mitochondrial degradation in neurons, and knockdown of USP30 rescues defective mitophagy caused by pathogenic mutations in parkin. Knockdown of USP30 in aDrosophila model improves mitochondrial integrity and survival in both parkin- and PINK1- deficient flies. Thus, USP30 inhibition is potentially beneficial for Parkinson's disease by promoting mitochondrial clearance and quality control.

A graphical representation of how cellular health can be affected by changes in the levels of mitophagy — the process by which cells dispose of mitochondria that have become defective or damaged. Insufficient or excessive mitophagy reduces cellular health, owing to accumulation of defective mitochondria or disposal of too many mitochondria, respectively. PINK1–parkin signalling promotes mitophagy, and Bingol et al.1 now find that an enzyme, USP30, opposes the action of the parkin enzyme and inhibits mitophagy (not shown). Thus, in cells that express both parkin and USP30, a balanced level of mitophagy is maintained.

Neurofibrillary Tangles (NFTs) are aggregates of hyperphosphorylated tau protein that are most commonly known as a primary marker of Alzheimer's Disease

Alzheimer's disease is a synaptic failure DJ Selkoe - Science, 2002 - sciencemag.org Abstract In its earliest clinical phase, Alzheimer's disease characteristically produces a  remarkably pure impairment of memory. Mounting evidence suggests that this syndrome  begins with subtle alterations of hippocampal synaptic efficacy prior to frank neuronal ... 2197회 인용 관련 학술자료 전체 27개의 버전 Web of Science: 1564 인용 저장

(a) Hypothetical relationship between Aβ level and synaptic activity (a) Hypothetical relationship between Aβ level and synaptic activity. Intermediate levels of Aβ enhance synaptic activity presynaptically, whereas abnormally high or low levels of Aβ impair synaptic activity by inducing postsynaptic depression or reducing presynaptic efficacy, respectively. (b) Within a physiological range, small increases in Aβ primarily facilitate presynaptic functions, resulting in synaptic potentiation38, 39. (c) At abnormally high levels, Aβ enhances LTD-related mechanisms, resulting in postsynaptic depression and loss of dendritic spines4, 7, 31, 46.